Bachem Holding AG

Company BCHMF

Last mentioned: 4d ago

Timeline

  1. Earnings Release

    Scheduled release of quarterly and full-year financial results for Bachem (BCHMF).

  2. Order Book Milestone

    Company reported record order intake driven by metabolic disease therapy demand.

  3. Capacity Expansion Phase

    Bachem announced a major investment in 'Building T' at its Bubendorf facility.

Stories mentioning Bachem Holding AG 1

Earnings Neutral

Bachem Earnings Preview: Peptide Demand and Capacity Expansion in Focus

Bachem (BCHMF) is set to report its quarterly financial results this Thursday, with investors closely monitoring the company's ability to scale production for the surging GLP-1 market. The Swiss peptide specialist remains a critical infrastructure provider for the global pharmaceutical industry's most profitable drug classes.

2 sources